Whereas there were no differences between the groups in the level of Aβ42 (the 42-amino acid isoform of β-amyloid being a diagnostic biomarker of AD) in CSF, tau in CSF, phospho-tau 181 in CSF, as well as in functional tests [121]. The gene discussed is MAPT; the disease is Alzheimer disease.